Skip to main content

Table 1 Baseline demographics of patients with first and second primary lung cancer

From: Therapeutic method for early-stage second primary non-small lung cancer: analysis of a population-based database

 

1st primary

(N = 1075)

2nd primary

(N = 1075)

Age (mean, y)

68.8 (9.0)

70.6 (9.0)

Histology

 Adenocarcinoma

649 (60.4%)

576 (53.6%)

 Squamous cell

245 (22.8%)

196 (18.2%)

 Other

181 (16.8%)

303 (28.2%)

Tumor size (mean, mm)

18.7 (6.4)

15.4 (6.3)

Tumor site

 Upper

680 (63.3%)

625 (58.1%)

 Middle

50 (4.6%)

61 (5.7%)

 Lower

332 (30.9%)

377 (35.1%)

 Not determined

13 (1.2%)

12 (1.1%)

Grade

 Well

195 (18.1%)

213 (19.8%)

 Moderately

402 (37.4%)

327 (30.4%)

 Poorly or undifferentiated

301 (28.0%)

189 (17.6%)

 Not determined

177 (16.5%)

346 (32.2%)

SEER stage

 In situ

5 (0.5%)

0 (0.0%)

 Localized

1070 (99.5%)

1075 (100.0%)

Types of surgery

 Lobectomy

538 (50.1%)

236 (22.0%)

 Sublobectomy

311 (28.9%)

395 (36.7%)

 No surgery

226 (21.0%)

444 (41.3%)